Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

September 2010

17

Erin Gainer, CEO of HRA Pharma, Recognized for Her Leadership Role in the Pharmaceutical Industry.

September 2010

17

HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada.

Août 2010

13

FDA grants approval of ella® for emergency contraception.

June 2010

17

FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception.

June 2010

15

Ulipristal acetate (ellaOne®) significantly reduces pregnancy risk versus levonorgestrel for oral emergency contraception.

May 2010

21

HRA Pharma's Partner Preglem Announces Positive Phase III Results for Ulipristal Acetate in the Treatment of Uterine Fibroids.

April 2010

27

HRA Pharma Announces FDA Advisory Committee Review of Ulipristal Acetate

April 2010

12

Preglem licenses additional rights for ulipristal acetate from HRA Pharm

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?